Oct 11, 2012, 10:00 AM by Michael Croft

PM Live | GlaxoSmithKline has released access to 200 compounds with possible action against tuberculosis in a move toward an "open innovation" approach to R&D.

Oct 11, 2012, 09:00 AM by Michael Croft

Forbes | The FDA took a generic version of Wellbutrin XL off the market yesterday because it just doesn't work--and hasn't worked for years.

Oct 10, 2012, 12:00 PM by Michael Croft

Oct 10, 2012, 09:00 AM by Michael Croft

Bio-IT World Roundup | The Nobel Prize in chemistry was awarded to two doctors for their work with G-protein-coupled receptors.

Oct 10, 2012, 08:00 AM by Michael Croft

Nature News | A paper slated to appear in the American Economic Review claims that a country's genetic diversity can predict the success of its economy. Critics worry that the paper is making claims that the inverse is also true.

Oct 9, 2012, 11:00 AM by Michael Croft

The Guardian | With the announcement of the Nobel Prize in physics, The Guardian looks at the pros and cons of scientific awards as rewards or as incentives.

Oct 8, 2012, 09:00 AM by Michael Croft

Oct 8, 2012, 08:00 AM by Michael Croft

eWeek | Health IT company NantHealth has introduced a supercomputing platform that it says can reduce the time required to analyze genomic data of a cancer patient from eight weeks to 47 seconds.

Oct 8, 2012, 07:00 AM by Michael Croft

eWeek | The University of Pittsburgh Medical Center has announced a five-year, $100 million investment in data warehousing and analytic tools incorporating IT infrastructure from dbMotion, IBM, Informatica, and Oracle.

Oct 8, 2012, 05:00 AM by Michael Croft

Computerworld | Graduate schools are recognizing the need for big-data degrees, and several have launched Master's programs in science or business analytics designed to train students to manage and process massive datasets.

Oct 5, 2012, 15:00 PM by Michael Croft

AZ Central | The Translational Genomics Research Institute is launching the TGen Center for Rare Childhood Disorders to use sequencing technology to identify rare diseases.

Oct 5, 2012, 08:05 AM by Michael Croft

Singularity HUB | A collaborative study investigated the genomes 825 breast cancer patients at different stages of disease.

Oct 5, 2012, 08:00 AM by Michael Croft

Reason.com | Ronald Bailey reports from the 4th Annual Consumer Genetics Conference. Among the highlights: GenePeeks, the Coriell Institute for Medical Research, the New York Genome Center, Life Technologies, Complete Genomics,GnuBio, and much more.

Oct 5, 2012, 08:00 AM by Michael Croft

Bio-IT World | PHILADELPHIA—BGI is leading a widespread call in the genomics research community for collaborations to extract medically useful information. At the inaugural International Conference on Genomics in the Americas (ICGA)*, held last week, BGI and Children’s Hospital of Philadelphia (CHOP) cohosted an exciting event with a host of dynamic presentations.

Oct 5, 2012, 08:00 AM by Michael Croft

Computerworld | EMC has named a new Chief Technology Officer. John Roese will play a key role in shaping EMC's big data and cloud strategy.

Oct 4, 2012, 15:05 PM by Michael Croft

Yahoo Finance | GnuBio has secured $10 million in additional funding. The company plans to use the money to commercialize its desktop DNA sequencing platform and hire additional staff in product development, molecular biology, informatics and software engineering.

Oct 4, 2012, 10:00 AM by Michael Croft

Oct 4, 2012, 07:00 AM by Michael Croft

Oct 3, 2012, 15:35 PM by Michael Croft

LA Times | Patrick Soon-Shiong, former UCLA surgeon and drug-company exec, has reached an agreement with Blue Shield of California to create a "continuous learning center" to work on spreading personalized medicine and best practices to more health care providers.

Oct 3, 2012, 14:40 PM by Michael Croft

Businessweek | Sarepta Therapeutics announced ground breaking clinical trial results today, when their drug for Duchenne muscular dystrophy helped patients walk nearly 300 feet farther than patients on placebo, and restored a key protein lacking in some patients.